Alterity Therapeutics Ratios (2009-2025) | ATHE

Ratios Jun2009 Dec2009 Jun2010 Dec2010 Jun2011 Dec2011 Jun2012 Dec2012 Jun2013 Dec2013 Jun2014 Dec2014 Jun2015 Dec2015 Jun2016 Dec2016 Jun2017 Dec2017 Jun2018 Dec2018 Jun2019 Dec2019 Jun2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025 Dec2025
Profitability
EBT Margin (Quarter)
-208.71%3,178.13%-222.66%-310.33%
EBIT Margin (Quarter)
-208.71%3,178.13%-222.66%-310.46%
EBITDA Margin (Quarter)
-208.71%3,178.13%-222.66%-310.46%
Net Margin (Quarter)
-208.71%3,178.13%-222.66%-310.33%
FCF Margin (Quarter)
-34.22%1,027.32%-300.98%142.67%
Efficiency
Assets Average (Quarter)
12.61B12.60B9.51B9.50B0.02B5.08B5.08B0.01B0.01B0.02B0.03B0.03B0.03B0.03B0.01B0.01B0.01B0.01B0.02B0.03B
Invested Capital (Quarter)
-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B
Asset Utilization Ratio (Quarter)
0.000.000.35
Leverage & Solvency
Interest Coverage Ratio (Quarter)
0.00B
Debt Ratio (Quarter)
Times Interest Earned (Quarter)
0.00B
Valuation
Enterprise Value (Quarter)
-0.02B-0.02B-0.02B-0.02B-0.01B-0.01B-0.01B-0.01B-0.01B-0.03B-0.02B-0.03B-0.02B-0.02B-0.00B-0.01B-0.00B-0.00B-0.02B-0.03B
Return Ratios
Return on Sales (Quarter)
-0.02%0.32%-0.02%-0.03%
Return on Capital Employed (Quarter)
-0.20%-0.19%-0.16%-127.83%-0.36%-0.43%-235.78%-95.64%-283.34%-189.03%
Return on Assets (Quarter)
0.00%0.00%0.00%-0.01%0.00%0.00%-0.02%-0.02%-0.01%0.00%0.00%0.00%-0.02%-0.03%-0.02%-0.02%-0.01%0.00%